Junling Liu
- Hematology top 1%
- Platelet Disorders and Treatments 48
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 15
- Physiology top 2%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- Immunology top 5%
- Immune Cell Function and Interaction 8
-
- Antiplatelet Therapy and Cardiovascular Diseases 12
-
- PI3K/AKT/mTOR signaling in cancer 11
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 7
-
- Blood properties and coagulation 6
Junling Liu
172 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 884
- Immunology and Allergy 256
- Physiology 144
- Cancer Research 446
- Immunology 615
Countries citing papers authored by Junling Liu
This map shows the geographic impact of Junling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Liu more than expected).
Fields of papers citing papers by Junling Liu
This network shows the impact of papers produced by Junling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Liu. The network helps show where Junling Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Isobutyrate Confers Resistance to Inflammatory Bowel Disease through Host–Microbiota Interactions in Pigsbreakdown → | 2025 | 18 |
| 2 | 2025 | 2 | |
| 3 | 2024 | 17 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 73 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 34 | |
| 13 | 2022 | 15 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 1 | |
| 17 | 2020 | 83 | |
| 18 | 2020 | 30 | |
| 19 | 2015 | 30 | |
| 20 | 2014 | 37 |
About Junling Liu
Junling Liu is a scholar working on Hematology, Immunology and Allergy and Cancer Research, having authored 181 papers that have together received 4.1k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (48 papers), Cell Adhesion Molecules Research (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Immune Cell Function and Interaction (8 papers), Cancer-related molecular mechanisms research (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Blood properties and coagulation (6 papers). The work is most often cited by research in Hematology (884 citations), Immunology and Allergy (256 citations) and Physiology (144 citations). Junling Liu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include T. Kent Gartner, Xiaoping Du, Michael C. Berndt, Carl W. Jackson, Zhenyu Li, Yi Zheng, Kemin Wang, Xuemei Fan, Lin Zhang and Yanyan Xu. Their work appears in journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology, Blood Advances, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.